Formulation, Characterization, and Stability of Protein Drugs : Case Histories /

Detalles Bibliográficos
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Pearlman, Rodney. (Editor ), Wang, Y. John. (Editor )
Formato: eBook
Lenguaje:English
Publicado: New York, NY : Springer US : Imprint: Springer, 2002.
Edición:1st ed. 2002.
Colección:Pharmaceutical Biotechnology, 9
Materias:
LEADER 02284nam a22003135i 4500
001 000283144
005 20220119104750.0
007 cr nn 008mamaa
008 100301s2002 xxu| s |||| 0|eng d
020 |a 9780306474521 
024 7 |a 10.1007/b112935  |2 doi 
040 |a Sistema de Bibliotecas del Tecnológico de Costa Rica 
245 1 0 |a Formulation, Characterization, and Stability of Protein Drugs :  |b Case Histories /  |c edited by Rodney Pearlman, Y. John Wang. 
250 |a 1st ed. 2002. 
260 # # |a New York, NY :  |b Springer US :  |b Imprint: Springer,  |c 2002. 
300 |a XXVIII, 432 p. :  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Pharmaceutical Biotechnology,  |v 9 
505 0 |a A Compendium and Hydropathy/ Flexibility Analysis of Common Reactive Sites in Proteins: Reactivity at Asn, Asp, Gin, and Met Motifs in Neutral pH Solution -- Characterization, Stability, and Formulations of Basic Fibroblast Growth Factor -- The Characterization, Stabilization, and Formulation of Acidic Fibroblast Growth Factor -- Stability, Characterization, Formulation, and Delivery System Development for Transforming Growth Factor-Beta1 -- Stability and Characterization of Recombinant Human Relaxin -- Interferon-?-1b (Betaseron®): A Model for Hydrophobic Therapeutic Proteins -- Characterization, Formulation, and Stability of Neupogen® (Filgrastim), a Recombinant Human Granulocyte-Colony Stimulating Factor -- Development and Shelf-Life Determination of Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (LEUKINE®, GM-CSF) -- Formulation Development of an Antifibrin Monoclonal Antibody Radiopharmaceutical -- Biophysical Characterization and Formulation of TP40: A Chimeric Protein that Requires a pH-Dependent Conformational Change for Its Biological Activity -- Stability Characterization and Formulation Development of Recombinant Human Deoxyribonuclease I [Pulmozyme®, (Dornase Alpha)]. 
650 0 |a Pharmacology. 
650 0 |a Pharmacy. 
650 1 4 |a Pharmacology/Toxicology. 
650 2 4 |a Pharmacy. 
700 1 |a Pearlman, Rodney.  |e editor. 
700 1 |a Wang, Y. John.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks